Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2-Reference-Cited by-同舟云学术

Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2

Published:2020-06-16 Issue:13 Volume:94 Page:
ISSN:0022-538X
Container-title:Journal of Virology
language:en
Short-container-title:J Virol

Author:

Nguyen Austin¹²^ORCID,David Julianne K.¹²^ORCID,Maden Sean K.¹²^ORCID,Wood Mary A.¹³^ORCID,Weeder Benjamin R.¹²^ORCID,Nellore Abhinav¹²⁴^ORCID,Thompson Reid F.¹²⁵⁶⁷^ORCID

Affiliation:

1. Computational Biology Program, Oregon Health & Science University, Portland, Oregon, USA

2. Department of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon, USA

3. Portland VA Research Foundation, Portland, Oregon, USA

4. Department of Surgery, Oregon Health & Science University, Portland, Oregon, USA

5. Department of Radiation Medicine, Oregon Health & Science University, Portland, Oregon, USA

6. Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, Oregon, USA

7. Division of Hospital and Specialty Medicine, VA Portland Healthcare System, Portland, Oregon, USA

Abstract

Individual genetic variation may help to explain different immune responses to a virus across a population. In particular, understanding how variation in HLA may affect the course of COVID-19 could help identify individuals at higher risk from the disease. HLA typing can be fast and inexpensive. Pairing HLA typing with COVID-19 testing where feasible could improve assessment of severity of viral disease in the population. Following the development of a vaccine against SARS-CoV-2, the virus that causes COVID-19, individuals with high-risk HLA types could be prioritized for vaccination.

Funder

Sunlin & Priscilla Chou Foundation

U.S. Department of Veterans Affairs

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/JVI.00510-20

Reference78 articles.

1. World Health Organization. 2020. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). WHO (World Health Organization), Geneva, Switzerland.

2. A Novel Coronavirus from Patients with Pneumonia in China, 2019

3. Roser M Ritchie HR Ortiz-Ospina E Hasell J. 2020. Coronavirus disease (COVID-19)—statistics and research. https://ourworldindata.org/coronavirus.

4. Estimation of risk factors for COVID-19 mortality - preliminary results

5. Systematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infection

Cited by 433 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene: environment interactions in immune and inflammatory responses to severe acute respiratory syndrome coronavirus 2 infection;Current Opinion in Immunology;2024-10

2. Association between human leukocyte antigen alleles and COVID-19 disease severity;Journal of Infection and Public Health;2024-09

3. COVID-19 in Pediatric Populations;Clinics in Chest Medicine;2024-09

4. Impact of HLA Alleles on COVID-19 Severity in Kidney Transplant Recipients: A Single-Center Study;Cureus;2024-08-26

5. T cell-mediated Immune response and correlates of inflammation and their relationship with COVID-19 clinical severity: not an intuitive guess;BMC Infectious Diseases;2024-06-20